Navigation Links
Kiwa Bio-Tech in Collaboration Discussions with Beijing Hai Xin Science and Technology Co., Ltd.
Date:5/19/2008

BEIJING and CLAREMONT, Calif.*, May 19 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced discussions with Beijing Hai Xin Science and Technology Co., Ltd. ("Hai Xin") regarding joint product development and marketing efforts. This May, the Board Chairman of Hai Xin, Mr. Haiming Sun, and Mr. Ming Yang, the CFO, visited Kiwa's Beijing headquarters.

Hai Xin is a high technology enterprise that specializes in mineral resource development of nonmetallic clays and earths in order to enhance the natural functions of the materials. By combining these earths with organic materials, improved bio-feeds and bio-fertilizers can be manufactured for farming operations.

Hai Xin has mineral resource exploitation rights for land that contains over 50,000,000 metric tons of palygorskite. The Company also holds several technology patents for processing palygorskite into feed additive products and agricultural fertilizer products.

Mr. Sun stated, "Hai Xin has determined that Kiwa's bio-fertilizer products and bio-feed products are gaining recognition and market share in China. Meanwhile, by dint of the development strength of China Agricultural University, Kiwa-CAU R&D Centre is a product development leader of China's agricultural technological industry."

Mr. Sun continued, "Hai Xin is examining the feasibility of assigning use of it's patents and technology related to mineral resources to Kiwa with the objective of working together to develop new products to improve farming in China. Hai Xin hopes cooperation with Kiwa to combine our palygorskite products with Kiwa's existing products and the efforts of Kiwa-CAU R&D Centre will allow further development of advanced agricultural products. We hope to work together marketing these products and expanding the marketing position of both companies."

ABOUT KIWA BIO-TECH PRODUCTS GROUP CORPORATION

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC (http://www.sec.gov) or visit the Company's website at http://www.kiwabiotech.com .

* Effective today, Kiwa's California office has moved to: 310 N. Indian

Hill Blvd., #702, Claremont, CA 91711

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward- looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

For more information, please contact:

Kiwa Bio-Tech Products Group Corporation

Yvonne Wang

310 N. Indian Hill Blvd., #702

Claremont CA 91711

Tel: +1-626-715-5855

Email: kiwabiotech@gmail.com

Robert Schechter

Equity Communications

Tel: +1-212-499-6809

Email: ir4kiwa@hotmail.com


'/>"/>
SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
2. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
3. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
4. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
5. Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month
6. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
7. Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million
8. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
9. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
10. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
11. Kiwa Bio-Tech Ships 114 Tons of Bio-Fertilizer in Fourth Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... , ... May 15, 2017 , ... Tunnell Consulting ... a presentation of “The Key Role of Specifications in Process Validation,” at the ... . The event will bring together leaders from the pharmaceutical and biotech industries to ...
(Date:5/15/2017)... ... May 15, 2017 , ... Algenist ... Lift Contouring Cream, a gravity-shattering cream with a patented formula, clinically proven to ... bring the Advanced Lift Contouring Cream to our already innovative ELEVATE product line,” ...
(Date:5/15/2017)... -- IBM (NYSE: IBM ) scientists have developed ... molecules with the potential to efficiently reveal biomarkers ... complements the IBM Research,s "lab-on-a-chip" nanoDLD technology ... which may also contain biomarkers for disease detection. ... diamond shaped micropillars 1 to pre-stretch DNA ...
(Date:5/12/2017)... , May 12, 2017  Eli Lilly and Company ... galcanezumab, an investigational treatment for the prevention of ... in three Phase 3 studies (EVOLVE-1, EVOLVE-2 and ... of monthly migraine headache days compared to placebo ... robust results from these three studies bring us ...
Breaking Biology Technology:
(Date:3/30/2017)... -- The research team of The Hong Kong Polytechnic ... by adopting ground breaking 3D fingerprint minutiae recovery and matching technology, ... accuracy for use in identification, crime investigation, immigration control, security of ... ... A research team led by Dr ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):